Background. We describe urinary neutrophil gelatinaseassociated lipocalin (uNGAL) values in association with clinical characteristics and urinary parameters in adults undergoing coronary angiography. Methods. This is an observational study of consecutive patients who underwent elective coronary angiography during a 4-month period in a large urban tertiary care hospital. Results. One hundred and thirteen patients were enrolled, and 100 had sufficient data to be included in the analyses. A large range of preprocedural uNGAL levels were observed (range 1-269 ng/mg Cr). Median preprocedural uNGAL was 8 ng/mg Cr. Age (P ¼ 0.009), serum creatinine (P ¼ 0.077) and albumin excretion (P ¼ 0.009) were significant predictors of baseline uNGAL. Half the cohort demonstrated an increase and half a decrease in the absolute values of uNGAL after angiography, irrespective of preprocedural levels. Conclusions. We observed variable, but relatively low absolute levels of uNGAL prior to angiography in this 'cardiac' cohort. Only age, serum creatinine and albumin excretion could explain some of this variability. When designing studies of at-risk individuals where uNGAL may be used as a marker for acute kidney injury, this variability should be taken into account.
Introduction
The use of new biomarkers in medicine has become topical in recent years. Rigorous description, validation and determination of appropriate discriminatory properties in different clinical scenarios are essential before adopting new biomarkers into clinical practice. In nephrology, markers that help to identify kidney injury earlier than changes in serum creatinine are being actively studied. One of the promising candidates is neutrophil gelatinase-associated lipocalcin (NGAL), a 25-kDa member of the lipocalcin family that is highly accumulated in blood and urine after nephrotoxic and ischemic renal insults [1, 2] .
NGAL has excellent operating characteristics in isolation for diagnosing acute kidney injury (AKI) in children, but in adults, NGAL has lower sensitivity and specificity for diagnosis and prognosis of AKI [3] [4] [5] [6] [7] [8] [9] [10] . Reasons for this include the following: NGAL is observed to be elevated to variable degrees at baseline, and with any renal insult, NGAL levels increase both in those who do and do not develop AKI [5] [6] [7] [8] 11] . NGAL been also been shown to correlate with several other parameters including renal function and proteinuria, and over time can predict progression in patients with chronic kidney disease (CKD) [8, [12] [13] [14] .
In order to add to this accumulating literature on NGAL and to aid in better understanding of this biomarker, we sought to describe NGAL variation in a cohort of stable patients with risk factors for cardiac disease prior to and after elective coronary angiography.
Materials and methods
This observational study received institutional ethics approval and adhered to the Declaration of Helsinki. All consecutive adults >18 years of age undergoing elective diagnostic and/or interventional cardiac catheterization at St. Paul's Hospital in Vancouver, Canada, over a 4-month period (August to November 2007) were included. 'Elective' refers to angiograms that were booked from a cardiologist's office on a nonurgent basis and performed as an outpatient. The majority of angiograms were ordered to reassess patients with a known history of cardiovascular disease or to assess for coronary atherosclerosis in patients with known valvular heart disease. Excluded from the study were those patients undergoing emergent cardiac catheterization or in whom imminent surgery was anticipated, patients in acute renal failure or on dialysis and those failing to sign informed consent.
The cardiac catheterizations were performed by an interventional cardiologist in a standard manner using a femoral approach. No specific protocols for intravenous fluids or medications were routinely administered to the study participants periprocedure. Two spot urine samples were collected: one immediately prior to angiography and the first-void after the cardiac catheterization procedure. Each sample was run in real-time for standard electrolytes, albumin/creatinine (ACR) and beta-2 microglobulin (b2M). The remaining urine was centrifuged at 2000 g for 5 min and the supernatants stored at À80°C for subsequent NGAL measurements. In the present study, the urine samples were collected and were an average of 5.5 h apart (SD 2.1 h). All subjects were discharged home from the angiography area within 8 h of their procedure.
Information collected at the time of cardiac catheterization included standard demographic data, comorbidity and medication profiles, procedural data (type and volume of contrast media, ejection fraction by contrast ventriculography) and baseline serum electrolytes and renal function. glomerular filtration rate (GFR) was calculated using the four-variable modified modification of diet in renal disease formula [15] .
The primary outcome measure of this study was NGAL levels pre-and postangiography. Our key objectives were to describe preprocedural urinary neutrophil gelatinase-associated lipocalin (uNGAL) variation in a cohort of patients undergoing cardiac catheterization including those with some degree of impaired kidney function/CKD, baseline clinical/laboratory associations and the direction of change in uNGAL after angiography.
NGAL measurements
The uNGAL measurements were performed according to the previously described methodology [3] , in an accredited laboratory with extensive experience in the analysis of NGAL. Briefly, uNGAL was analyzed using the ARCHITECTÒ standardized clinical platform. This assay utilizes high-affinity antibodies generated toward distinct epitopes on NGAL. The assay is a two-step (sandwich) assay using chemiluminescent microparticle immunoassay technology. The functional sensitivity (i.e. lower reportable limit) of the ARCHITECT assay is 2 ng/mL. With a range that extends up to 1500 ng/mL, the coefficient of variation of this assay is <5%. Urine creatinine was measured using quantitative colorimetric Microplate Assay Kit (Oxford Biomedical Research, Oxford, MA) to standardize uNGAL for changes in urine concentration.
Statistics
Demographic variables for the study cohort were summarized using percentages, means with SD or medians with interquartile ranges depending on the underlying distribution of the variables. Associations between baseline uNGAL and the potential risk factors were assessed using the Spearman's correlation coefficient (for the continuous variables) and the Wilcoxon rank-sum test (for the categorical variables). Any risk factors in the univariate association analyses with a P-value of 0.15 were put forth into a multiple linear regression model to further examine the relationship with baseline uNGAL. A logarithm transformation on baseline uNGAL was used as the dependent variable in order to satisfy the model assumptions for the regression model. All results were analyzed using uNGAL both normalized and not normalized for urinary creatinine; as the results were similar, we have only presented the data using uNGAL normalized for urinary creatinine. A P-value of 0.05 was regarded as statistically significant. All analyses were done in SPSS Version 16.0 (Chicago, IL).
Results
A total of 113 subjects were enrolled; however, n ¼ 13 (11.5%) were not included in the analysis as a post procedural urine was not available (subjects unable to void). No significant differences existed between the group with and without second urine tests. Table 1 describes the demographics of the population included for study. A quarter of the population had diabetes, median serum creatinine was 83 lmol/L, GFR 75 mL/min and ACR ratio 0.9 mg/mmol. Eighteen percent of the cohort had CKD as defined by GFR <60 mL/min. Figure 1 describes the distribution of preprocedural uNGAL in the entire cohort; median uNGAL was 8 ng/mg Cr. Tables 2 and 3 describe correlations between preprocedural uNGAL and other urinary markers as well as demographic characteristics. uNGAL (P 0.10) was statistically significantly correlated with weight, serum creatinine, urinary sodium, urine ACR and urine b2M. Table 4 describes variables that were independently associated with preprocedural uN-GAL and include age, serum creatinine and urinary ACR.
Preprocedural uNGAL and associated variables
Changes in uNGAL after coronary angiography Figure 2 describes the absolute change in uNGAL after coronary angiography in the cohort both normalized (Figure 2A) and not normalized ( Figure 2B ) for urine creatinine and in those with CKD ( Figure 2c ). Note that there was no discernable pattern of uNGAL change postangiography among the cohort, regardless of CKD status.
Discussion
This study systematically describes the uNGAL variability at baseline and after elective cardiac catheterization, in a cohort of outpatient adults, 18% of whom have impaired kidney function. While others have described some variability in uNGAL, we describe here not only the large preprocedure variation in uNGAL levels, but an apparent randomness to the changes post procedure, irrespective of preprocedure levels.
In agreement with other investigators, we were able to describe predictors of a higher preprocedural uNGAL including age, serum creatinine and urinary albumin creatinine ratio [8, 12, 13] . Contrary to other investigators, however, we observed an inverse correlation between serum creatinine and uNGAL. Reasons for this are not entirely known; in our cohort, age was directly associated with uNGAL levels, and it is known that older patients tend to have a lower lean body mass resulting in a lower serum creatinine. Intravascular volume depletion from diuretic use, of which almost 40% were prescribed, may have further contributed to this inverse relationship as uNGAL has been shown to be mildly elevated in prerenal injury [16] . The finding of an inverse correlation between weight and uNGAL (À0.223, P ¼ 0.03, univariate) and between urinary sodium and uNGAL (À0.240, P ¼ 0.02, univariate), respectively, lends support to this hypothesis. Important to note are the relatively low absolute levels of uNGAL in this 'cardiac' cohort prior to angiography; the median uNGAL was 8 ng/mg Cr. This is well below the reported range of uNGAL used to diagnose AKI [10] . We also observed wide variations in uNGAL levels. In addition to age and renal disease, we hypothesize that a potentially modifiable factor, volume status, may have been playing a role as there was no uniform 'hydration' protocol prior to angiography. Depending on the volume of fluids received peri-procedurally, this factor likely contributed to the variations in post-angiography uNGAL levels as well. None of the other urinary markers measured (urinary sodium, calcium or b2M) were independent predictors of baseline uNGAL. Only urinary sodium (inverse correlation) and b2M (direct correlation) were significantly correlated univariately, but not in multivariate testing. These relationships are likely lost when renal function is considered as urinary sodium can be reflective of volume status, and b2M elevation can reflect some degree of tubular injury [17] .
This study is exploratory and as such has limitations. The major limitation is lack of serum creatinine values after cardiac procedures, and thus, we are not able to correlate changes in uNGAL with changes in serum creatinine and an ultimate outcome of interest, i.e. AKI. It is likely the incidence of AKI was quite low given that uNGAL is known to increase sharply in magnitude within hours of a renal insult. The small sample size and heterogeneity of the population may also be construed as a limitation. However, these too are relative, as the values determined would represent the spectrum found in clinical practice. The use of a central laboratory and strict protocols for collection and storage make the possibility of laboratory error as an explanation for the variation unlikely. Overall, our results are restricted to exploring what determines baseline variability in uNGAL in a stable 'cardiac' population.
In conclusion, we observed wide variation in uNGAL levels in an ambulatory cardiac population prior to angiography, albeit at low levels. Predictors of baseline uNGAL are age, serum creatinine and albumin excretion.
